Journal Pre-proof Biosimilars in developed economies: Overview, status, and regulatory considerations Anurag S. Rathore, Ankita Bhargava PII: S0273-2300(19)30289-2 DOI: https://doi.org/10.1016/j.yrtph.2019.104525 Reference: YRTPH 104525 To appear in: Regulatory Toxicology and Pharmacology Received Date: 14 June 2019 Revised Date: 7 November 2019 Accepted Date: 8 November 2019 Please cite this article as: Rathore, A.S., Bhargava, A., Biosimilars in developed economies: Overview, status, and regulatory considerations, Regulatory Toxicology and Pharmacology (2019), doi: https:// doi.org/10.1016/j.yrtph.2019.104525. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Published by Elsevier Inc.